Abstract

This systematic review explores caregiver barriers to HPV vaccination in the African-American and Afro-Caribbean population in order to guide health promotion strategies to counteract existing obstacles to HPV vaccination, particularly in this population who is disproportionately affected by higher rates of HPV and HPV-associated cancers than most others.

Author Details

Gabriella M. Riccio, DNP, MSN, ARNP, FNP-BC, Cynthia Michel-Knowles DO., PA, Plantation, Florida, USA; Eric Fenkl, PhD, RN, CNE; Charles P. Buscemi, PhD; Audrey P. Miller, PhD, MSNEd, ARNP, PPCNP-BC -- Nicole Wertheim College of Nursing and Health Sciences, Florida International University, Miami, Florida, USA

Sigma Membership

Pi Alpha

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

African-American and Afro-Caribbean, Human Papillomavirus, Immunization Barriers

Conference Name

29th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Melbourne, Australia

Conference Year

2018

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (1433 kB)

Share

COinS
 

Caregiver barriers to HPV vaccination in the African American and Afro-Caribbean population

Melbourne, Australia

This systematic review explores caregiver barriers to HPV vaccination in the African-American and Afro-Caribbean population in order to guide health promotion strategies to counteract existing obstacles to HPV vaccination, particularly in this population who is disproportionately affected by higher rates of HPV and HPV-associated cancers than most others.